Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof

Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof

US Patent 11168129 · Granted Nov 9, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-influenza neuraminidase monoclonal antibodies and uses thereof2025
Anti-influenza neuraminidase monoclonal antibodies and uses thereof2025
Anti-influenza neuraminidase monoclonal antibodies and uses thereof2025
Anti-influenza neuraminidase monoclonal antibodies and uses thereof2025
Multivalent live-attenuated influenza vaccine for prevention and control of equi2025
Anti-influenza neuraminidase monoclonal antibodies and uses thereof2024
Anti-influenza neuraminidase monoclonal antibodies and uses thereof2024
Anti-influenza neuraminidase monoclonal antibodies and uses thereof2024
Anti-influenza neuraminidase monoclonal antibodies and uses thereof2024
Multivalent live-attenuated influenza vaccine for prevention and control of equi2023
Live-attenuated vaccine having mutations in viral polymerase for the treatment a2021
Human monoclonal antibodies to human endogenous retrovirus K envelope (HERV-K) a2021